LINC01094 acts as a competitive endogenous RNA in ccRCC and plays a tumor-promoting contribution to the progress of ccRCC through the microRNA 224-5p/chondroitin synthase 1 (CHSY1) regulatory axis [36]. The gene discussed is LINC01094; the disease is neoplasm.